News.bms.com

Bristol Myers Squibb

WEBCamzyos is the first and only FDA-approved cardiac myosin inhibitor that specifically targets the source of obstructive HCM Approval based on groundbreaking …

Actived: 5 days ago

URL: https://news.bms.com/news/details/2022/U.S.-Food-and-Drug-Administration-Approves-Camzyos-mavacamten-for-the-Treatment-of-Adults-With-Symptomatic-New-York-Heart-Association-Class-II-III-ObstructiveHypertrophic-Cardiomyopathy-HCM-to-Improve-Functional-Capacity-and-Symptoms/default.aspx

Bristol Myers Squibb

WEBMavacamten, a potential first-in-class cardiac myosin inhibitor for patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), showed …

Category:  Health Go Health

Bristol Myers Squibb

WEBOncologists, surgeons, and specialists surveyed cite long-term survival, prevention of relapse or recurrence and quality of life as most important factors when …

Category:  Health Go Health

Bristol Myers Squibb

WEBBristol Myers Squibb’s Sotyktu, a first-in-class, oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, is the only approved TYK2 inhibitor worldwide and the …

Category:  Health Go Health

Bristol Myers Squibb

WEBCompany Awards $1.8M in Grants to Eight Organizations in Brazil, India, Thailand and the United Kingdom Bristol Myers Squibb (NYSE: BMY) today unveiled a $1.8 million …

Category:  Health Go Health

Bristol Myers Squibb

WEBAbecma is the first BCMA-directed CAR T cell therapy to demonstrate superiority versus standard regimens in relapsed and refractory multiple myeloma Bristol …

Category:  Health Go Health

Bristol Myers Squibb

WEBBristol Myers Squibb (NYSE:BMY) today announced, in collaboration with Disability Solutions, a U.S.- based non-profit organization that supports companies …

Category:  Health Go Health

Bristol Myers Squibb

WEB52 physicians from across the U.S. selected for the inaugural cohort of the five-year, $100 million initiative Initiative is part of the BMS Foundation commitment to …

Category:  Health Go Health

Voluntis and Bristol-Myers Squibb to Co-Develop Digital …

WEBVoluntis (Euronext Paris, Ticker: VTX - ISIN: FR0004183960), a leader in digital therapeutics, and Bristol-Myers Squibb Company (NYSE:BMY) today announced …

Category:  Health Go Health

Bristol Myers Squibb

WEBBristol Myers Squibb (NYSE: BMY) today announced an expansion of its existing patient support programs to help eligible unemployed patients in the U.S. who …

Category:  Health Go Health

Bristol Myers Squibb

WEBBristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the TD Cowen 44 th Annual Health Care Conference in Boston, …

Category:  Health Go Health

Bristol Myers Squibb Board Elects Two New Independent Directors

WEBBristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has elected two new independent directors, Ms. Paula A. Price and Mr. Derica …

Category:  Health Go Health

Updated Statement: Bristol Myers Squibb on Coronavirus (COVID …

WEBThroughout the unprecedented and evolving COVID-19 pandemic, Bristol Myers Squibb has focused on protecting the health and safety of our workforce, …

Category:  Health Go Health

Bristol Myers Squibb

WEBResults add to the growing body of evidence and reinforce the efficacy profile of Sotyktu, a once-daily, oral, selective, allosteric tyrosine kinase 2 (TYK2) …

Category:  Health Go Health

Bristol Myers Squibb

WEBIn light of the COVID-19 pandemic, GRYT Health (“grit”), a digital health company with a social purpose and creator of the Global Virtual Cancer Conference and …

Category:  Cancer Go Health

Bristol-Myers Squibb Announces Offer from Taisho Pharmaceutical

WEBStrategic review process announced in June concludes with a project to sell UPSA consumer health business The potential transaction would position Bristol-Myers …

Category:  Health Go Health

Bristol Myers Squibb

WEBNew Educational Program Improves Science Education, Focuses on Career Opportunities More than 75 Newark high school students and teachers today probe the …

Category:  Health Go Health

Bristol Myers Squibb

WEBGlobal advocacy platform born out of need during COVID-19 expands offerings with the goal of helping better support patients as they navigate health care …

Category:  Health Go Health

Bristol-Myers Squibb Announces Leadership Changes

WEBNEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that John Elicker, Executive Vice President, Corporate …

Category:  Health Go Health

Bristol Myers Squibb

WEBApproximately 9.5 million people in the U.S. are projected to have AFib in 2023, with the number expected to rise to approximately 12.1 million by 2030; many …

Category:  Health Go Health

Bristol Myers Squibb Reports Second Quarter 2020 Financial Results

WEBBristol Myers Squibb (NYSE:BMY) today reports results for the second quarter of 2020, which reflect strong product sales, continued advancement of the pipeline and robust …

Category:  Health Go Health